Added to YB: 2024-07-14
Pitch date: 2024-07-14
GRAL [bullish]
GRAIL, Inc.
+244.93%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
Market Cap
$2.0B
Pitch Price
$15.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.13
P/E
-4.38
EV/Sales
7.57
Sector
Biotechnology
Category
N/A
Show full summary:
GRAIL INC GRAL
A summary for this pitch has not been created yet.
Read full article (0 min)